Extensive-stage small-cell lung cancer
Clinical trials for Extensive-stage small-cell lung cancer explained in plain language.
Never miss a new study
Get alerted when new Extensive-stage small-cell lung cancer trials appear
Sign up with your email to follow new studies for Extensive-stage small-cell lung cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lung cancer drug combo trial halted early
Disease control Stopped earlyThis study tested a new combination of cancer drugs (bemarituzumab plus anlotinib) against a standard treatment (tislelizumab) for people with extensive-stage small cell lung cancer. The goal was to see if the new combo could delay cancer growth or improve survival. However, the …
Matched conditions: EXTENSIVE-STAGE SMALL-CELL LUNG CANCER
Phase 2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Lung cancer maintenance combo trial stopped early
Disease control Stopped earlyThis study tested whether adding the drug vorolanib to standard maintenance therapy with atezolizumab could help people with extensive-stage small cell lung cancer stay cancer-free longer after initial chemotherapy. Only 11 participants were enrolled before the study was terminat…
Matched conditions: EXTENSIVE-STAGE SMALL-CELL LUNG CANCER
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Experimental combo for tough lung cancer shows early promise, but study halted
Disease control Stopped earlyThis early-phase trial tested an experimental antibody called hSTC810 combined with the chemotherapy drug paclitaxel in 10 adults with relapsed or refractory extensive-stage small cell lung cancer. The goal was to see if the combination is safe and helps shrink tumors or slow the…
Matched conditions: EXTENSIVE-STAGE SMALL-CELL LUNG CANCER
Phase 1/2 • Sponsor: STCube, Inc. • Aim: Disease control
Last updated Jun 26, 2026 14:13 UTC
-
Can a smartphone app ease cancer treatment side effects?
Symptom relief Stopped earlyThis study tested whether a digital health app (Roche DPM Module) helps cancer patients manage symptoms and reduce healthcare visits while on systemic treatment. About 49 participants used the app alongside standard care. The trial was terminated early, so results are limited.
Matched conditions: EXTENSIVE-STAGE SMALL-CELL LUNG CANCER
Phase 2/3 • Sponsor: Hoffmann-La Roche • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC